Alibaba Health Information Technology

HKG:241 · BMG0171K1018

Food & Staples RetailingLarge

360

Medium confidence — indicative

Value28

Profit price19

Cash yield28

Owner Earnings Yield21

Dividend Yield35

Sales & asset price20

Price/Sales18

EV / Gross Profit20

Price/Book22

Quality41

Returns on capital33

Return on Capital27

Return on Equity39

Profit margins41

EBIT Margin46

Gross Profitability35

Cash backing40

Cash Conversion1

Accruals78

Growth53

Sales growth68

Profit growth90

Profit Growth83

Long-Term EPS Growth97

Reinvestment77

Price momentum24

Safety—

Debt load97

Debt serviceability31

Liquidity94

Sentiment54

Analyst ratings39

Expectations trend74

Opinion Changes50

Price Target Upside97

Market mood69

Value Creation10/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Alibaba Health Information Technology clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryHong Kong SAR China

IndustryFood & Staples Retailing

SizeLarge

TypePublic Company

ExchangeSEHK

Founded1998

Employees20

Websitealihealth.cn

ISINBMG0171K1018

Last UpdateApr 2, 2026

Indices

Hang Seng (Hong Kong)

Themes

Information TechnologyWellnessWireless

Description

Analysis

Hope premium

Alibaba Health Information Technology Limited is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium.

Valuation data is not available for this company.

Growth is moderate; the safety picture is uncertain. The company scores 10/20 on our value-creation score: creating some value.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Mar 2026

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Alibaba Health Information Technology with its peers

Uxin

NSQ:UXIN

CountryChina

IndustrySpecialty Retail

SizeSmall

Full Stock Analysis →

Codan

ASX:CDA

CountryAustralia

IndustryElectronic Equipment, Instruments & Components

SizeMedium

Full Stock Analysis →

Imdex

ASX:IMD

CountryAustralia

IndustryMetals & Mining

SizeMedium

Full Stock Analysis →

GS Retail

KSC:007070

CountrySouth Korea

IndustryFood & Staples Retailing

SizeMedium

Full Stock Analysis →

Sinopharm

HKG:1099

CountryChina

IndustryHealth Care Providers & Services

SizeX-Large

Full Stock Analysis →

Omron

TYO:6645

CountryJapan

IndustryElectronic Equipment, Instruments & Components

SizeX-Large

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →